Ombitasvir, Paritaprevir, Ritonavir and Dasabuvir Mini-Tabs Plus Ribavirin for Children Aged 3‒11 Years with Hepatitis C Genotype 1a Article Swipe
Related Concepts
Ombitasvir
Ritonavir
Paritaprevir
Ribavirin
Medicine
Dasabuvir
Discontinuation
Hepatitis C
Internal medicine
Gastroenterology
Adverse effect
Virology
Viral load
Hepatitis C virus
Virus
Antiretroviral therapy
Philip Rosenthal
,
Michael R. Narkewicz
,
Betty Yao
,
Christopher D. Jolley
,
Steven Lobritto
,
Jessica Wen
,
Jean P. Molleston
,
Evelyn Hsu
,
Maureen M. Jonas
,
Jiuhong Zha
,
Li Liu
,
Daniel H. Leung
·
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.6084/m9.figshare.12293216
· OA: W3186994594
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.6084/m9.figshare.12293216
· OA: W3186994594
Related Topics
Finding more related topics…